“…The in vivo significance of the EGF signaling pathway in controlling GnRH function is suggested by experiments showing that the expression of TGFα, erbB1, erbB2, erbB4 and the enzymatic activity of tumor necrosis factor-α-converting enzyme (TACE), a metalloproteinase involved in the ectodomain shedding of TGFα and the subsequent activation of erbB1 in response to glutamatergic inputs [26], increase in the hypothalamus at the time of puberty [20,24,26,27,28]. Moreover, the in vivo deregulation of TGFα/erbB1 [23,27,29,30,31,32] or erbB2 signaling [20], or the inhibition of TACE activity [26], perturbs the onset of female puberty. The crucial role of astrocytic erbB signaling in the control of reproductive function has been demonstrated in transgenic mice expressing a dominant-negative erbB4 receptor in astrocytes, which selectively blocks the ligand-dependent activation of erbB4 and erbB2 receptors in these cells [21].…”